华绿生物2月24日获融资买入1087.17万元,融资余额7947.21万元

Core Viewpoint - Hualu Green Biotechnology Co., Ltd. shows strong financial performance with significant revenue growth and profit increase, indicating potential investment opportunities in the edible mushroom sector [2]. Group 1: Financial Performance - As of September 30, Hualu Green achieved operating revenue of 868 million yuan, a year-on-year increase of 17.98% [2]. - The net profit attributable to shareholders reached 16.33 million yuan, reflecting a substantial year-on-year growth of 146.55% [2]. - Cumulative cash dividends since the company's A-share listing amount to 76.79 million yuan, with 46.44 million yuan distributed over the past three years [2]. Group 2: Shareholder and Market Activity - As of September 30, the number of Hualu Green's shareholders decreased by 9.42% to 10,300, while the average circulating shares per person increased by 11.88% to 9,132 shares [2]. - On February 24, Hualu Green's stock price rose by 1.27%, with a trading volume of 101 million yuan, and a net financing purchase of 2.57 million yuan [1]. - The financing balance as of February 24 was 79.47 million yuan, accounting for 2.72% of the circulating market value, indicating a high level of financing activity [1].

CHINAGREEN BIO-华绿生物2月24日获融资买入1087.17万元,融资余额7947.21万元 - Reportify